Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis

Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China

(2021) Jialei Hu et al.   Human Vaccines & Immunotherapeutics

Meta-analysis of immunogenicity and safety of human rabies vaccination under Zagreb and Essen regimens

(2020) Ting Li et al.   Journal of Comparative Effectiveness Research

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial

(2020) Heng Shen et al.   Human Vaccines & Immunotherapeutics

Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis

(2018) Annefleur C Langedijk et al.   CLINICAL INFECTIOUS DISEASES

Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination

(2018) Jatuporn Sirikun et al.   VACCINE

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above

(2017) Jing Wang et al.   Human Vaccines & Immunotherapeutics

Rabies

(2017) Anthony R. Fooks et al.   Nature Reviews Disease Primers

Network meta-analysis: an introduction for clinicians

(2016) Benjamin Rouse et al.   Internal and Emergency Medicine

Safety comparison of four types of rabies vaccines in patients with WHO category II animal exposure

(2016) Jun Peng et al.   MEDICINE

A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes

(2016) Anuradha Bose et al.   VACCINE

Correction: Estimating the Global Burden of Endemic Canine Rabies

(2015) Katie Hampson et al.   PLoS Neglected Tropical Diseases

Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China

(2014) Quan Hu et al.   Human Vaccines & Immunotherapeutics

Comparison of Safety and Immunogenicity of PVRV and PCECV Immunized in Patients with WHO Category II Animal Exposure: A Study Based on Different Age Groups

(2014) Yuan Fang et al.   PLoS Neglected Tropical Diseases

Rabies Immunization of Travelers in a Canine Rabies Endemic Area

(2013) Suda Sibunruang et al.   JOURNAL OF TRAVEL MEDICINE

Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman–Moore strain) manufactured in India

(2013) Doddabele Hanumanthaiah Ashwath Narayana et al.   Human Vaccines & Immunotherapeutics

An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (Rabivax®) in Indian subjects

(2011) M.K. Sudarshan et al.   Human vaccines & immunotherapeutics

The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen

(2011) Huazhang Liu et al.   Human vaccines & immunotherapeutics

Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis

(2011) Ling-yun Wang et al.   VACCINE

Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV)

(2011) Ahmad Fayaz et al.   VACCINE

A comparative study on the safety and immunogenicity of purified duck embryo cell vaccine (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab)

(2009) Doddabele Hanumantaiah Ashwathnarayana et al.   VACCINE